Cytomegalovirus infection following marrow transplantation: risk, treatment, and prevention.
D000914:Antibodies, Viral / Q000276:immunology; D000998:Antiviral Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000209:etiology* / Q000517:prevention & control; D006086:Graft vs Host Disease / Q000209:etiology; D006098:Granulocytes / Q000637:transplantation; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000008:administration & dosage; D007370:Interferon Type I / Q000627:therapeutic use; D011024:Pneumonia, Viral / Q000209:etiology; D011183:Postoperative Complications / Q000209:etiology; D012306:Risk; D013997:Time Factors
D000914:Antibodies, Viral; D000998:Antiviral Agents; D007136:Immunoglobulins; D007370:Interferon Type I